Halesaga launches new health and wellness products with Discounts

Halesaga, a prominent health and wellness brand, has announced the launch of a new line of wellness goods with a 5 per cent discount on prepaid orders...

Biological E. Limited reduces Corbevax price to Rs 250 a dose

Biological E (BE) produced Corbevax vaccine shot for children has reduced the price of its COVID-19 vaccine, from Rs. 840 to Rs.250 a dose inclusive of GST,for private COVID-19 vaccination centres...

SII seeks goverment's nod to manufacture, stockpile qHPV vaccine against cervical cancer

The Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human Papillomavirus (qHPV) vaccine against cervical cancer after the completion of the phase 2/3 clinical...

CCMB develops India's first mRNA vaccine candidate against coronavirus

The Hyderabad-based CSIR-Centre for Cellular and Molecular Biology (CCMB) on Friday announced the development of a potential mRNA vaccine candidate against SARS-CoV-2, the virus which causes Covid-19. The Hyderabad-based CSIR-Centre for Cellular and

Zydus Lifesciences launches treatment for bad cholesterol

Zydus Lifesciences on Friday said it has launched in India its Bempedoic acid drug under the Bemdac brand for treatment of uncontrolled levels of bad cholesterol...

Sun Pharma gets USFDA approval for generic drug Mesalamine extended release capsules

Sun Pharmaceutical Industries on Thursday said it has received final approval from the US health regulator for Mesalamine extended release capsules, used to treat bowel disease, in the American market...

Immunotherapy Market Riding the Wave of Growth

There has been a rise in the adaptation of new therapeutics for the treatment of diseases and increase in implementation in the healthcare sector is creating new opportunities for the players of this market.

Roche Pharma launches PHESGO in India for the cure of HER-2 positive breast cancer

Roche Pharma on Thursday announced the launch of PHESGO, the fixed dose combination of two monoclonal antibodies in oncology for the treatment of HER-2 positive breast cancer now available in India...

Bayer announced the launch of antifungal brand Canesten in India

The Consumer Health division of Bayer announced the launch of the new and improved range of Canesten, thier anti-fungal treatment solution in India...

Alembic Pharma gets final USFDA authorization for chronic bronchitis and COPD medication

Alembic Pharmaceuticals Limited (Alembic) announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Arformoterol Tartrate Inhalation Solution...

© 2025 India Pharma Outlook. All Rights Reserved.